These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16731760)

  • 1. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics.
    Gerweck LE; Vijayappa S; Kozin S
    Mol Cancer Ther; 2006 May; 5(5):1275-9. PubMed ID: 16731760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell transmembrane pH gradient in tumors enhances cytotoxicity of specific weak acid chemotherapeutics.
    Kozin SV; Shkarin P; Gerweck LE
    Cancer Res; 2001 Jun; 61(12):4740-3. PubMed ID: 11406545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of weak electrolytes after the adaptation of cells to low pH: role of the transmembrane pH gradient.
    Kozin SV; Gerweck LE
    Br J Cancer; 1998 May; 77(10):1580-5. PubMed ID: 9635832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hypoxia and low pH on the cytotoxicity of chlorambucil.
    Skarsgard LD; Chaplin DJ; Wilson DJ; Skwarchuk MW; Vinczan A; Kristl J
    Int J Radiat Oncol Biol Phys; 1992; 22(4):737-41. PubMed ID: 1544846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular pH, transmembrane distribution and cytotoxicity of chlorambucil.
    Mikkelsen RB; Asher C; Hicks T
    Biochem Pharmacol; 1985 Jul; 34(14):2531-4. PubMed ID: 4015693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of intracellular pH control and relationship to cytotoxicity of chlorambucil and vinblastine.
    Parkins CS; Chadwick JA; Chaplin DJ
    Br J Cancer Suppl; 1996 Jul; 27():S75-7. PubMed ID: 8763851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor acidity, ion trapping and chemotherapeutics. II. pH-dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents.
    Raghunand N; Mahoney BP; Gillies RJ
    Biochem Pharmacol; 2003 Oct; 66(7):1219-29. PubMed ID: 14505801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH and chemotherapy.
    Raghunand N; Gillies RJ
    Novartis Found Symp; 2001; 240():199-211; discussion 265-8. PubMed ID: 11727930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute metabolic alkalosis enhances response of C3H mouse mammary tumors to the weak base mitoxantrone.
    Raghunand N; Mahoney B; van Sluis R; Baggett B; Gillies RJ
    Neoplasia; 2001; 3(3):227-35. PubMed ID: 11494116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of pH in murine tumor and muscle.
    Gerweck LE; Rhee JG; Koutcher JA; Song CW; Urano M
    Radiat Res; 1991 May; 126(2):206-9. PubMed ID: 2023990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG).
    Kuin A; Aalders M; Lamfers M; van Zuidam DJ; Essers M; Beijnen JH; Smets LA
    Br J Cancer; 1999 Feb; 79(5-6):793-801. PubMed ID: 10070871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of chlorambucil cytotoxicity by combination with flavone acetic acid in a murine tumour.
    Parkins CS; Chadwick JA; Chaplin DJ
    Anticancer Res; 1994; 14(4A):1603-8. PubMed ID: 7979193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
    Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of chemotherapy by manipulation of tumour pH.
    Raghunand N; He X; van Sluis R; Mahoney B; Baggett B; Taylor CW; Paine-Murrieta G; Roe D; Bhujwalla ZM; Gillies RJ
    Br J Cancer; 1999 Jun; 80(7):1005-11. PubMed ID: 10362108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pH partition theory predicts the accumulation and toxicity of doxorubicin in normal and low-pH-adapted cells.
    Gerweck LE; Kozin SV; Stocks SJ
    Br J Cancer; 1999 Feb; 79(5-6):838-42. PubMed ID: 10070878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice.
    Gao ZG; Lee DH; Kim DI; Bae YH
    J Drug Target; 2005 Aug; 13(7):391-7. PubMed ID: 16308207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.
    Gerweck LE; Seetharaman K
    Cancer Res; 1996 Mar; 56(6):1194-8. PubMed ID: 8640796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of pH-responsive PEG-hyperbranched polyacylhydrazone micelles for cancer therapy.
    Yu J; Deng H; Xie F; Chen W; Zhu B; Xu Q
    Biomaterials; 2014 Mar; 35(9):3132-44. PubMed ID: 24439411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.